Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125424472 | 12542447 | 2 | F | 20160616 | 20160628 | 20160708 | 20160711 | EXP | US-ASTRAZENECA-2016SE73170 | ASTRAZENECA | 3.00 | MON | M | Y | 6.10000 | KG | 20160711 | CN | CO | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125424472 | 12542447 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 30 | UG/KG | Y | 0 | 15 | UG/KG | INJECTION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125424472 | 12542447 | 1 | Bronchopulmonary dysplasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125424472 | 12542447 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125424472 | 12542447 | Bronchiolitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125424472 | 12542447 | 1 | 20160407 | 20160512 | 0 |